373 related articles for article (PubMed ID: 34163421)
1. Immunotherapies for Neurodegenerative Diseases.
Mortada I; Farah R; Nabha S; Ojcius DM; Fares Y; Almawi WY; Sadier NS
Front Neurol; 2021; 12():654739. PubMed ID: 34163421
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as a therapeutic treatment for neurodegenerative disorders.
White AR; Hawke SH
J Neurochem; 2003 Nov; 87(4):801-8. PubMed ID: 14622111
[TBL] [Abstract][Full Text] [Related]
3. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.
Kudrna JJ; Ugen KE
Hum Vaccin Immunother; 2015; 11(8):1921-6. PubMed ID: 26125436
[TBL] [Abstract][Full Text] [Related]
4. Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.
Lambour J; Naranjo-Gomez M; Piechaczyk M; Pelegrin M
Emerg Microbes Infect; 2016 Aug; 5(8):e92. PubMed ID: 27530750
[TBL] [Abstract][Full Text] [Related]
5. Neurodegenerative diseases as proteinopathies-driven immune disorders.
Ciccocioppo F; Bologna G; Ercolino E; Pierdomenico L; Simeone P; Lanuti P; Pieragostino D; Del Boccio P; Marchisio M; Miscia S
Neural Regen Res; 2020 May; 15(5):850-856. PubMed ID: 31719246
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Parkinson's disease: Current status and future directions.
Chatterjee D; Kordower JH
Neurobiol Dis; 2019 Dec; 132():104587. PubMed ID: 31454546
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of malignant diseases--developments and prospects].
Paukovits P; Himmler G; Loibner H
Wien Med Wochenschr; 2004 May; 154(9-10):235-41. PubMed ID: 15244049
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Arevalo-Villalobos JI; Rosales-Mendoza S; Zarazua S
Expert Rev Vaccines; 2017 Feb; 16(2):151-159. PubMed ID: 27579524
[TBL] [Abstract][Full Text] [Related]
10. Current status of immunotherapy in B cell malignancies.
Kofler DM; Mayr C; Wendtner CM
Curr Drug Targets; 2006 Oct; 7(10):1371-4. PubMed ID: 17073599
[TBL] [Abstract][Full Text] [Related]
11. Folate-targeted immunotherapies: Passive and active strategies for cancer.
Farran B; Pavitra E; Kasa P; Peela S; Rama Raju GS; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Feb; 45():45-52. PubMed ID: 30770191
[TBL] [Abstract][Full Text] [Related]
12. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
13. Emerging Immunotherapies for Parkinson Disease.
Zella SMA; Metzdorf J; Ciftci E; Ostendorf F; Muhlack S; Gold R; Tönges L
Neurol Ther; 2019 Jun; 8(1):29-44. PubMed ID: 30539376
[TBL] [Abstract][Full Text] [Related]
14. [Cancer immunotherapy--current status].
Kundig TM; Renner Ch; Knuth A
Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
[TBL] [Abstract][Full Text] [Related]
15. Update on Mucin-1 immunotherapy in cancer: a clinical perspective.
Rivalland G; Loveland B; Mitchell P
Expert Opin Biol Ther; 2015; 15(12):1773-87. PubMed ID: 26453294
[TBL] [Abstract][Full Text] [Related]
16. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.
Maguire-Zeiss KA; Federoff HJ
J Neuroimmune Pharmacol; 2009 Sep; 4(3):298-308. PubMed ID: 18931916
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapies in Huntington's disease and α-Synucleinopathies.
Fatoba O; Ohtake Y; Itokazu T; Yamashita T
Front Immunol; 2020; 11():337. PubMed ID: 32161599
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer immunotherapy.
McNeel DG
Curr Opin Urol; 2007 May; 17(3):175-81. PubMed ID: 17414515
[TBL] [Abstract][Full Text] [Related]
19. Passive immunization against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies.
Abiko Y
Crit Rev Oral Biol Med; 2000; 11(2):140-58. PubMed ID: 12002812
[TBL] [Abstract][Full Text] [Related]
20. Recent advance in immunotherapies for Alzheimer disease: with special reference to DNA vaccination.
Okura Y; Matsumoto Y
Hum Vaccin; 2009 Jun; 5(6):373-80. PubMed ID: 19221518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
